Alcon Inc. (LON:0A0D)
London · Delayed Price · Currency is GBP · Price in CHF | Market Cap | 27.17B -13.9% |
| Revenue (ttm) | 8.19B +8.3% |
| Net Income | 484.63M -40.1% |
| EPS | 0.99 -39.2% |
| Shares Out | n/a |
| PE Ratio | 56.07 |
| Forward PE | 18.37 |
| Dividend | 0.27 (0.50%) |
| Ex-Dividend Date | May 5, 2026 |
| Volume | 2,464,229 |
| Open | 61.40 |
| Previous Close | 58.50 |
| Day's Range | 60.20 - 62.12 |
| 52-Week Range | 48.08 - 79.39 |
| Beta | 0.69 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 11, 2026 |
About Alcon
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS... [Read more]
Financial Performance
In 2025, Alcon's revenue was $10.40 billion, an increase of 4.94% compared to the previous year's $9.91 billion. Earnings were $980.00 million, a decrease of -3.73%.
Financial numbers in USD Financial StatementsNews
Alcon Earnings Call Transcript: Q2 2026
Q2 2026 saw 7% sales growth, driven by strong adoption of UNITY equipment, PanOptix Pro IOL, and robust contact lens and ocular health performance. Core margins and EPS improved, with guidance reaffirmed for 5%-7% sales growth and 12%-15% EPS growth. Key launches and innovation are expected to sustain momentum.
Alcon Quarterly report: Q2 2026
Alcon has published its Q2 2026 quarterly earnings report on August 11, 2026.
Alcon Earnings release: Q2 2026
Alcon released its Q2 2026 earnings on August 11, 2026, summarizing the period's financial results.
Alcon Slides: Q2 2026
Alcon has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 11, 2026.
Eye care company Alcon raises profitability outlook, cuts tariff hit estimate
Swiss-American eye care company Alcon on Monday hiked its profit guidance and lowered its estimate for the full-year tariff impact to $40 million to $90 million, factoring in an anticipated refund ...
Alcon Q2 Core EPS Rises
(RTTNews) - Alcon Inc. (ALC) reported Tuesday that its second-quarter net income attributable to shareholders was nil, compared with $176 million, or $0.35 per share, in the year-ago quarter.
Alcon (ALC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Alcon (ALC) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street esti...
Alcon reports Q2 EPS 84c, consensus 76c
Reports Q2 revenue $2.78B, consensus $2.77B. “Our team delivered strong second-quarter results and executed well across the business,” said David J. Endicott, Alcon’s (ALC) Chief Executive Officer. “U...
Alcon raises FY26 EPS growth view to 12%-15% from 10%-13%
Consensus $3.47. Affirms FY26 revenue growth view of 5%-8%, consensus $11.13B. This outlook assumes the following: Aggregated markets grow approximately 3% to 4%. As of the end of July the…
Alcon up 5% above $77 after Q2 results, FY26 EPS guide raise
16:44 EDT Alcon (ALC) up 5% above $77 after Q2 results, FY26 EPS guide raise
New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
GENEVA--(BUSINESS WIRE)--New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth.
Is It Too Late to Buy Alcon Inc (ALC) After 3.3% Rally? GF Value Says Undervalued
Is It Too Late to Buy Alcon Inc (ALC) After 3.3% Rally? GF Value Says Undervalued
Alcon (ALC) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Alcon (ALC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarte...
Alcon (ALC) Unveils Advanced Training Center for Vitreoretinal Surgery
Alcon (ALC) Unveils Advanced Training Center for Vitreoretinal Surgery
Alcon opens second center with Aravind Eye Care System
Aravind Eye Care System and Alcon (ALC) announced the launch of the Aravind Alcon Global Centre of Excellence for Vitreoretinal Surgery Training in Coimbatore. Building on the launch of the…
A Look at Alcon Inc (ALC) After 3.8% Decline -- GF Value $91.41 vs Price $67.35
A Look at Alcon Inc (ALC) After 3.8% Decline -- GF Value $91.41 vs Price $67.35
Alcon price target lowered to $80 from $85 at Mizuho
Mizuho lowered the firm’s price target on Alcon (ALC) to $80 from $85 and keeps an Outperform rating on the shares. The firm adjusted targets in the medical device and…
Alcon Inc (ALC) Shares Fall 3.1% -- What GF Score of 71 Tells Investors
Alcon Inc (ALC) Shares Fall 3.1% -- What GF Score of 71 Tells Investors
RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook
RxSight NASDAQ: RXST reported preliminary second-quarter financial results and provided updates on its product pipeline following a newly announced strategic collaboration agreement with Alcon, with m...
RxSight Updates FY2026 Revenue Outlook After Alcon Deal; Cuts Product Sales Forecast; Stock Down
(RTTNews) - RxSight, Inc. (RXST), a commercial-stage ophthalmic medical device company, announced preliminary financial results for the second quarter of 2026 and updated the full-year 2026 guidance f...
Alcon Inks Partnership With RxSight To Develop Adjustable PICOLs For Deal Value Up To $200 Mln
(RTTNews) - Alcon Inc. (ALC), an eye care company specializing in surgical and vision care products, on Monday announced that it has entered into a non-exclusive collaboration with RxSight, Inc. (RXST...
Mexican Gold Mining Corp.: Alcon Silver Announces Shareholder Approval of Arrangement
Vancouver, British Columbia--(Newsfile Corp. - July 6, 2026) - Alcon Silver Corp. ("Alcon") and Mexican Gold Mining Corp. (TSXV: MEX) ("Mexican Gold") announce that, in connection with the previou...
Alcon Silver Announces Shareholder Approval of Arrangement
Vancouver, British Columbia--(Newsfile Corp. - July 6, 2026) - Alcon Silver Corp. ("Alcon") and Mexican Gold Mining Corp. (TSXV: MEX) ("Mexican Gold") announce that, in connection with the previously ...
Alcon (ALC) Partners with RxSight for Innovative Lens Development
Alcon (ALC) Partners with RxSight for Innovative Lens Development
Alcon, RxSight enter non-exclusive pact to develop adjustable PCIOLs
Alcon (ALC) and RxSight (RXST) announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting intraocular lenses, or PCIOLs. Under the collaboration, the companies will be...